1. N-Methyl antitumour agents

   • David Newell
   • Andreas Gescher
   • Christine Rutty

   Review Pages: 91 - 102

2. Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity

   • Ahmed E. Ahmed
   • Martin Grissom
   • John Costanzi

   Original Article Pages: 103 - 108

3. Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity

   • N. W. Kretschmer
   • P. J. Boor
   • E. S. Reynolds

   Original Article Pages: 109 - 117

4. Studies on the mechanism of cytotoxicity of 3′-deoxyadenosine N¹-oxide in different strains of Ehrlich ascites tumor cells

   • Karsten R. Svendsen
   • Kay Overgaard-Hansen
   • Svend Aage Engelholm

   Original Article Pages: 118 - 122

5. Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells

   • DeWayne Roberts
   • Taisheng Lee
   • Richard Ashmun

   Original Article Pages: 123 - 130

6. Chemotherapeutic agents do not interact with neurotransmitter receptors

   • Stephen J. Peroutka

   Original Article Pages: 131 - 132

7. Pharmacokinetics of ametantrone acetate (NSC-287513)

   • John G. Kuhn
   • Carol E. Balmer
   • Antonio J. Grillo-Lopez

   Original Article Pages: 133 - 137

8. Clinical pharmacology of oral and intravenous 4-demethoxydaunorubicin

   • David B. Smith
   • Jennifer M. Margison
   • Anthony Howell

   Original Article Pages: 138 - 142

9. Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma

   • Bjørn Hagen
   • Frode Walseth
   • Odd G. Nilsen

   Original Article Pages: 143 - 148

10. Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells

    • Paul A. Andrews
    • Michael P. Murphy
    • Stephen B. Howell

    Original Article Pages: 149 - 154

11. High-dose cisplatin in advanced head and neck cancer

    • Arlene A. Forastiere
    • Bonnie J. Takasugi
    • Vickie Kudla-Hatch

    Original Article Pages: 155 - 158

12. Failure to preserve fertility in patients with Hodgkin's disease

    • J. H. Waxman
    • R. Ahmed
    • T.A. Lister

    Original Article Pages: 159 - 162

13. Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemia

    • Zalmen Arlin
    • Rakesh Mehta
    • Anthony Pucillo

    Original Article Pages: 163 - 164

14. Treatment of refractory chronic lymphocytic leukemia with prednimustine: A phase II study using strict response criteria

    • David R. Gandara
    • Christopher B. George
    • Jerry P. Lewis

    Original Article Pages: 165 - 168

15. A phase II study of high-dose cytosine arabinoside in the treatment of acute leukaemia in adults

    • Michael J. Barnett
    • Ama Z. S. Rohatiner
    • T. Andrew Lister

    Original Article Pages: 169 - 171

16. Extensive stage small cell carcinoma of the bronchus

    • Graham M. Mead
    • Joyce Thompson
    • Christopher J. Williams

    Original Article Pages: 172 - 174

17. Antibodies to 4-hydroxyandrostenedione — a new anti-breast cancer agent suitable for use in a radioimmunoassay

    • J. Khubieh
    • G. W. Aherne
    • J. Chakraborty

    Short Communication Pages: 175 - 176

18. Third trimester chemotherapy and neonatal hematopoiesis

    • Josephine M. Meador
    • Steven A. Armentrout
    • Lewis M. Slater

    Short Communication Pages: 177 - 179

19. High dose etoposide does not cause peripheral neuropathy

    • T. J. Littlewood
    • D. P. Bentley
    • I. N. F. McQueen

    Letter to the Editors Pages: 180 - 181

20. Meeting announcements

    Announcement Pages: 182 - 182